Advertisement
Advertisement
Pharmaniaga Gliclazide

Pharmaniaga Gliclazide

gliclazide

Manufacturer:

Pharmaniaga Manufacturing Berhad

Distributor:

Pharmaniaga Logistics
Concise Prescribing Info
Contents
Gliclazide
Dosage/Direction for Use
40-80 mg daily. Max single dose: Not to exceed 160 mg, split into bd dosing for higher doses. Elderly Initially, 40 mg bd as morning & evening doses.
Administration
Should be taken with food.
Contraindications
Hypersensitivity to other sulphonylureas & related drugs. IDDM, diabetic ketoacidosis, diabetic coma & pre-coma, hyperosmolar non-ketotic coma, after severe burns, trauma or during infections, diabetics undergoing surgery. Severe renal & hepatic insufficiency. Pregnancy.
Special Precautions
Severe diarrhoea & gastroparesis, intestinal obstruction, prolonged vomiting, hyper- & hypoglycaemia, hypothyroidism. Patients suffering from intercurrent infections, traumas, shock or after anaesth. May affect ability to drive & use machines. Renal impairment, hepatic disease. Not recommended during pregnancy. Not to be used during lactation. Paed patients.
Adverse Reactions
GI disturbances, metallic taste; increased appetite, wt gain; skin rashes, pruritus, photosensitivity; hypoglycaemia.
Drug Interactions
Disulfiram-like reaction w/ alcohol. Increased anticoagulant effects w/ coumarin- or indandione-derivative anticoagulants. Potentiated hypoglycaemic action w/ sulphonamides, salicylates, phenylbutazone, β-adrenoreceptor blockers, MAOIs, ketoconazole, miconazole. Diminution of hypoglycaemic action w/ thiazide diuretics, corticosteroids, oestrogens.
MIMS Class
Antidiabetic Agents
ATC Classification
A10BB09 - gliclazide ; Belongs to the class of sulfonylureas. Used in the treatment of diabetes.
Presentation/Packing
Form
Pharmaniaga Gliclazide tab 80 mg
Packing/Price
6 × 10's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement